DR. ROBERT LECHLEIDER, M.D.
Osteopathic Medicine at Brook Ln, Bethesda, MD

License number
Maryland D0054659
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
116 N Brook Ln, Bethesda, MD 20814
Phone
(240) 994-8659

Personal information

See more information about ROBERT LECHLEIDER at radaris.com
Name
Address
Phone
Robert Lechleider, age 63
116 N Brook Ln, Bethesda, MD 20814
(301) 656-5096
Robert J Lechleider
116 N Brook Ln, Bethesda, MD 20814
(301) 656-5096
Robert J Lechleider
5514 Johnson Ave, Bethesda, MD 20817
(301) 656-5096
Robert J Lechleider, age 63
116 Brook Ln, Bethesda, MD 20814
(301) 656-5096
Robert J Lechleider, age 63
116 Brook Ln, Bethesda, MD 20814
(301) 656-5096

Organization information

See more information about ROBERT LECHLEIDER at bizstanding.com

Robert Lechleider MD

116 N Brk Ln, Bethesda, MD 20814

Industry:
Internist
Phone:
(240) 994-8659 (Phone)
Robert Joseph Lechleider

Professional information

Robert Lechleider Photo 1

Dr. Robert Lechleider, Bethesda MD - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
116 N Brook Ln, Bethesda 20814
(240) 994-8659 (Phone)
Certifications:
Internal Medicine, 2007, Medical Oncology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1990


Robert Lechleider Photo 2

Novel Human Septin And Uses Therefor

US Patent:
2003012, Jul 3, 2003
Filed:
Jul 29, 2002
Appl. No.:
10/208304
Inventors:
Sarit Larisch - Zichron-Yaakov, IL
Seong-Jin Kim - Bethesda MD, US
Robert Lechleider - Bethesda MD, US
Anita Roberts - Bethesda MD, US
Youngsuk Yi - Redwood City CA, US
Assignee:
The Government of the United States of America - Rockville MD
International Classification:
C12Q001/68, C07H021/04, C12N009/64, C12P021/02, C12N005/06
US Classification:
435/006000, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200
Abstract:
The invention provides a newly identified and isolated nucleotide sequence encoding a polypeptide referred to in the present application as ARTS, for Apoptosis Related protein in the TGF- Signaling pathway.